home.social

#epilipidnet — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #epilipidnet, aggregated by home.social.

fetched live
  1. If you haven't already listened to our latest #podcast with Corinne Spickett discussing Redox Biology and includes an overview of the #EpiLipidNET games then CLICK THE LINK NOW to listen!! www.lipidmaps.org/resources/ed...

  2. Zhixu Ni presenting LipidCXSMILES developed together with @egonw and #epilipidnet and #lipidmaps here at #MetSoc2025 bridging real lipid chemical structures, and the uncertainty because MS gives only so much structural hints.

  3. Zhixu Ni presenting LipidCXSMILES developed together with @egonw and #epilipidnet and #lipidmaps here at #MetSoc2025 bridging real lipid chemical structures, and the uncertainty because MS gives only so much structural hints.

  4. Zhixu Ni presenting LipidCXSMILES developed together with @egonw and #epilipidnet and #lipidmaps here at #MetSoc2025 bridging real lipid chemical structures, and the uncertainty because MS gives only so much structural hints.

  5. Zhixu Ni presenting LipidCXSMILES developed together with @egonw and #epilipidnet and #lipidmaps here at #MetSoc2025 bridging real lipid chemical structures, and the uncertainty because MS gives only so much structural hints.

  6. Only the highest level indicates enough evidence on the double bond location and the stereochemistry. That this is a thing is shown by the article which I posted about earlier today: social.edu.nl/@egonw/112444260 #epilipidnet

  7. Only the highest level indicates enough evidence on the double bond location and the stereochemistry. That this is a thing is shown by the article which I posted about earlier today: social.edu.nl/@egonw/112444260 #epilipidnet

  8. Only the highest level indicates enough evidence on the double bond location and the stereochemistry. That this is a thing is shown by the article which I posted about earlier today: social.edu.nl/@egonw/112444260 #epilipidnet

  9. Only the highest level indicates enough evidence on the double bond location and the stereochemistry. That this is a thing is shown by the article which I posted about earlier today: social.edu.nl/@egonw/112444260 #epilipidnet

  10. Only the highest level indicates enough evidence on the double bond location and the stereochemistry. That this is a thing is shown by the article which I posted about earlier today: social.edu.nl/@egonw/112444260 #epilipidnet

  11. NH reminds us why we do FAIR, for the I and the R. Why? Ideally reusability, but we can settle for now interpretability.

    He then talks us through various approaches on how to annotated experimentally measured lipids with identifiers and their certainty.

    E.g. the scoring levels reflecting how much evidence have for the structural detail #epilipidnet

  12. NH reminds us why we do FAIR, for the I and the R. Why? Ideally reusability, but we can settle for now interpretability.

    He then talks us through various approaches on how to annotated experimentally measured lipids with identifiers and their certainty.

    E.g. the scoring levels reflecting how much evidence have for the structural detail #epilipidnet

  13. NH reminds us why we do FAIR, for the I and the R. Why? Ideally reusability, but we can settle for now interpretability.

    He then talks us through various approaches on how to annotated experimentally measured lipids with identifiers and their certainty.

    E.g. the scoring levels reflecting how much evidence have for the structural detail #epilipidnet

  14. NH reminds us why we do FAIR, for the I and the R. Why? Ideally reusability, but we can settle for now interpretability.

    He then talks us through various approaches on how to annotated experimentally measured lipids with identifiers and their certainty.

    E.g. the scoring levels reflecting how much evidence have for the structural detail #epilipidnet

  15. NH reminds us why we do FAIR, for the I and the R. Why? Ideally reusability, but we can settle for now interpretability.

    He then talks us through various approaches on how to annotated experimentally measured lipids with identifiers and their certainty.

    E.g. the scoring levels reflecting how much evidence have for the structural detail #epilipidnet

  16. jumping to the last #epilipidnet session, another few interesting talks, like the previous session, very practical. There is a lot of great lipids use cases in the clinic heading our way.

    I cannot, however, not post about @TheLipidHoff's talk, the last one of the day and whole meeting: "Proposition of a scoring system for data quality assessment in MS-based #lipidomics"

  17. jumping to the last #epilipidnet session, another few interesting talks, like the previous session, very practical. There is a lot of great lipids use cases in the clinic heading our way.

    I cannot, however, not post about @TheLipidHoff's talk, the last one of the day and whole meeting: "Proposition of a scoring system for data quality assessment in MS-based #lipidomics"

  18. jumping to the last #epilipidnet session, another few interesting talks, like the previous session, very practical. There is a lot of great lipids use cases in the clinic heading our way.

    I cannot, however, not post about @TheLipidHoff's talk, the last one of the day and whole meeting: "Proposition of a scoring system for data quality assessment in MS-based #lipidomics"

  19. jumping to the last #epilipidnet session, another few interesting talks, like the previous session, very practical. There is a lot of great lipids use cases in the clinic heading our way.

    I cannot, however, not post about @TheLipidHoff's talk, the last one of the day and whole meeting: "Proposition of a scoring system for data quality assessment in MS-based #lipidomics"

  20. jumping to the last #epilipidnet session, another few interesting talks, like the previous session, very practical. There is a lot of great lipids use cases in the clinic heading our way.

    I cannot, however, not post about @TheLipidHoff's talk, the last one of the day and whole meeting: "Proposition of a scoring system for data quality assessment in MS-based #lipidomics"

  21. this article (onlinelibrary.wiley.com/doi/10) corrects the chemical structure of DAT₂ (HT Matt from LIPID MAPS)

    It cites five articles that had the wrong structure: "This means that a number of studies provides an incorrect structure of mycolipanolic acid and DAT₂. [9, 20, 21, 39]"

    I annotated these citations with CiTO intentions and created a nanopublication: w3id.org/np/RApE4XpLLnxs3HtbYD #epilipidnet

  22. this article (onlinelibrary.wiley.com/doi/10) corrects the chemical structure of DAT₂ (HT Matt from LIPID MAPS)

    It cites five articles that had the wrong structure: "This means that a number of studies provides an incorrect structure of mycolipanolic acid and DAT₂. [9, 20, 21, 39]"

    I annotated these citations with CiTO intentions and created a nanopublication: w3id.org/np/RApE4XpLLnxs3HtbYD #epilipidnet

  23. this article (onlinelibrary.wiley.com/doi/10) corrects the chemical structure of DAT₂ (HT Matt from LIPID MAPS)

    It cites five articles that had the wrong structure: "This means that a number of studies provides an incorrect structure of mycolipanolic acid and DAT₂. [9, 20, 21, 39]"

    I annotated these citations with CiTO intentions and created a nanopublication: w3id.org/np/RApE4XpLLnxs3HtbYD #epilipidnet

  24. this article (onlinelibrary.wiley.com/doi/10) corrects the chemical structure of DAT₂ (HT Matt from LIPID MAPS)

    It cites five articles that had the wrong structure: "This means that a number of studies provides an incorrect structure of mycolipanolic acid and DAT₂. [9, 20, 21, 39]"

    I annotated these citations with CiTO intentions and created a nanopublication: w3id.org/np/RApE4XpLLnxs3HtbYD #epilipidnet

  25. this article (onlinelibrary.wiley.com/doi/10) corrects the chemical structure of DAT₂ (HT Matt from LIPID MAPS)

    It cites five articles that had the wrong structure: "This means that a number of studies provides an incorrect structure of mycolipanolic acid and DAT₂. [9, 20, 21, 39]"

    I annotated these citations with CiTO intentions and created a nanopublication: w3id.org/np/RApE4XpLLnxs3HtbYD #epilipidnet

  26. one main point they bring up is that using [M+Ag]+ a lot of MS properties improve, making metabolites a lot easier to detect, see e.g. scholia.toolforge.org/work/Q12 #epilipidnet

  27. one main point they bring up is that using [M+Ag]+ a lot of MS properties improve, making metabolites a lot easier to detect, see e.g. scholia.toolforge.org/work/Q12 #epilipidnet

  28. one main point they bring up is that using [M+Ag]+ a lot of MS properties improve, making metabolites a lot easier to detect, see e.g. scholia.toolforge.org/work/Q12 #epilipidnet

  29. one main point they bring up is that using [M+Ag]+ a lot of MS properties improve, making metabolites a lot easier to detect, see e.g. scholia.toolforge.org/work/Q12 #epilipidnet

  30. one main point they bring up is that using [M+Ag]+ a lot of MS properties improve, making metabolites a lot easier to detect, see e.g. scholia.toolforge.org/work/Q12 #epilipidnet

  31. the third #epilipidnet meeting day has started,with a keynote by Prof. Ingela Lanekoff (#UppsalaUniversitet) focussing on new technologies to measure metabolites. Her @wdscholia page: scholia.toolforge.org/author/Q

  32. the third #epilipidnet meeting day has started,with a keynote by Prof. Ingela Lanekoff (#UppsalaUniversitet) focussing on new technologies to measure metabolites. Her @wdscholia page: scholia.toolforge.org/author/Q

  33. the third #epilipidnet meeting day has started,with a keynote by Prof. Ingela Lanekoff (#UppsalaUniversitet) focussing on new technologies to measure metabolites. Her @wdscholia page: scholia.toolforge.org/author/Q

  34. the third #epilipidnet meeting day has started,with a keynote by Prof. Ingela Lanekoff (#UppsalaUniversitet) focussing on new technologies to measure metabolites. Her @wdscholia page: scholia.toolforge.org/author/Q

  35. the third #epilipidnet meeting day has started,with a keynote by Prof. Ingela Lanekoff (#UppsalaUniversitet) focussing on new technologies to measure metabolites. Her @wdscholia page: scholia.toolforge.org/author/Q

  36. after the coffee break we continue with the #epilipidnet session on #lipidomics in health and disease (well, we say a lot of that already, but then again, human health does involve a lot of research funding). Here ceramides, like Cer(16:0) though not the class but a specific instance was shown on the slide (basically, wrong identifier; but this only stresses that we rather have some redundant/overlapping info than too little, leaving us to guessing).

  37. after the coffee break we continue with the #epilipidnet session on #lipidomics in health and disease (well, we say a lot of that already, but then again, human health does involve a lot of research funding). Here ceramides, like Cer(16:0) though not the class but a specific instance was shown on the slide (basically, wrong identifier; but this only stresses that we rather have some redundant/overlapping info than too little, leaving us to guessing).

  38. after the coffee break we continue with the #epilipidnet session on #lipidomics in health and disease (well, we say a lot of that already, but then again, human health does involve a lot of research funding). Here ceramides, like Cer(16:0) though not the class but a specific instance was shown on the slide (basically, wrong identifier; but this only stresses that we rather have some redundant/overlapping info than too little, leaving us to guessing).

  39. after the coffee break we continue with the #epilipidnet session on #lipidomics in health and disease (well, we say a lot of that already, but then again, human health does involve a lot of research funding). Here ceramides, like Cer(16:0) though not the class but a specific instance was shown on the slide (basically, wrong identifier; but this only stresses that we rather have some redundant/overlapping info than too little, leaving us to guessing).

  40. after the coffee break we continue with the #epilipidnet session on #lipidomics in health and disease (well, we say a lot of that already, but then again, human health does involve a lot of research funding). Here ceramides, like Cer(16:0) though not the class but a specific instance was shown on the slide (basically, wrong identifier; but this only stresses that we rather have some redundant/overlapping info than too little, leaving us to guessing).

  41. if you wonder why #epilipidnet WG4 was missing, that's the WG where we're involved. Florian Gruber (the chair) presented some recent work on lipids in our skins and how cholesterol modulates restructuring of the membranes and the tissue structure. I (co-chair) presented the @wikipathways work (tho I see I should not have left out the @bridgedb slide) and the state of the #lipids portal (lipids.wikipathways.org/).

  42. if you wonder why #epilipidnet WG4 was missing, that's the WG where we're involved. Florian Gruber (the chair) presented some recent work on lipids in our skins and how cholesterol modulates restructuring of the membranes and the tissue structure. I (co-chair) presented the @wikipathways work (tho I see I should not have left out the @bridgedb slide) and the state of the #lipids portal (lipids.wikipathways.org/).

  43. if you wonder why #epilipidnet WG4 was missing, that's the WG where we're involved. Florian Gruber (the chair) presented some recent work on lipids in our skins and how cholesterol modulates restructuring of the membranes and the tissue structure. I (co-chair) presented the @wikipathways work (tho I see I should not have left out the @bridgedb slide) and the state of the #lipids portal (lipids.wikipathways.org/).

  44. if you wonder why #epilipidnet WG4 was missing, that's the WG where we're involved. Florian Gruber (the chair) presented some recent work on lipids in our skins and how cholesterol modulates restructuring of the membranes and the tissue structure. I (co-chair) presented the @wikipathways work (tho I see I should not have left out the @bridgedb slide) and the state of the #lipids portal (lipids.wikipathways.org/).

  45. if you wonder why #epilipidnet WG4 was missing, that's the WG where we're involved. Florian Gruber (the chair) presented some recent work on lipids in our skins and how cholesterol modulates restructuring of the membranes and the tissue structure. I (co-chair) presented the @wikipathways work (tho I see I should not have left out the @bridgedb slide) and the state of the #lipids portal (lipids.wikipathways.org/).

  46. WG5 is the dissemination WG. Again, plenty of papers, but the games are particularly interesting. Lipodrome, Burn Your Fats! are two of them. #epilipidnet

  47. WG5 is the dissemination WG. Again, plenty of papers, but the games are particularly interesting. Lipodrome, Burn Your Fats! are two of them. #epilipidnet

  48. WG5 is the dissemination WG. Again, plenty of papers, but the games are particularly interesting. Lipodrome, Burn Your Fats! are two of them. #epilipidnet

  49. WG5 is the dissemination WG. Again, plenty of papers, but the games are particularly interesting. Lipodrome, Burn Your Fats! are two of them. #epilipidnet

  50. WG5 is the dissemination WG. Again, plenty of papers, but the games are particularly interesting. Lipodrome, Burn Your Fats! are two of them. #epilipidnet

  51. WG3 is now presenting. One of the things shown by Alex Dickens (Turku) is results for validation of a mass scale device to measure blood lipids (#bileAcids).

    Are we going to see a new era of diagnostics in human health? #epilipidnet

  52. WG3 is now presenting. One of the things shown by Alex Dickens (Turku) is results for validation of a mass scale device to measure blood lipids (#bileAcids).

    Are we going to see a new era of diagnostics in human health? #epilipidnet

  53. WG3 is now presenting. One of the things shown by Alex Dickens (Turku) is results for validation of a mass scale device to measure blood lipids (#bileAcids).

    Are we going to see a new era of diagnostics in human health? #epilipidnet

  54. WG3 is now presenting. One of the things shown by Alex Dickens (Turku) is results for validation of a mass scale device to measure blood lipids (#bileAcids).

    Are we going to see a new era of diagnostics in human health? #epilipidnet

  55. WG3 is now presenting. One of the things shown by Alex Dickens (Turku) is results for validation of a mass scale device to measure blood lipids (#bileAcids).

    Are we going to see a new era of diagnostics in human health? #epilipidnet